These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8232801)

  • 1. Low-grade astrocytomas may arise from different astrocyte lineages.
    Piepmeier JM; Fried I; Makuch R
    Neurosurgery; 1993 Oct; 33(4):627-32. PubMed ID: 8232801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2B5 lineages of human astrocytic tumors and their recurrence.
    Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
    Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual lineage of astrocytomas.
    Bishop M; de la Monte SM
    Am J Pathol; 1989 Sep; 135(3):517-27. PubMed ID: 2551172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
    Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
    J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.
    Schramm J; Luyken C; Urbach H; Fimmers R; Blümcke I
    Neurosurgery; 2004 Aug; 55(2):340-7; discussion 347-8. PubMed ID: 15271240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
    Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
    Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro identification and functional characterization of glial precursor cells in human gliomas.
    Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic staining patterns of human glioma cultures: primary cultures, long-term cultures and cell lines.
    Westphal M; Nausch H; Herrmann HD
    J Neurocytol; 1990 Aug; 19(4):466-77. PubMed ID: 2243242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supratentorial gliomas: a comparative study by grade and histologic type.
    Shaw EG; Scheithauer BW; O'Fallon JR
    J Neurooncol; 1997 Feb; 31(3):273-8. PubMed ID: 9049856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
    Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
    Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
    Benzil DL; Finkelstein SD; Epstein MH; Finch PW
    Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas.
    Brehar FM; Arsene D; Brinduse LA; Gorgan MR
    Brain Tumor Pathol; 2015 Apr; 32(2):90-8. PubMed ID: 25178519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical quantitative study of glial fibrillary acid protein and vimentin of astrocytomas].
    Xu QZ; Duan HL; Lu DH
    Zhonghua Bing Li Xue Za Zhi; 1994 Apr; 23(2):66-8. PubMed ID: 8082240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uniform lineage of oligodendrogliomas.
    de la Monte SM
    Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
    Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
    Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
    Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of supratentorial astrocytoma WHO grade II.
    Peraud A; Ansari H; Bise K; Reulen HJ
    Acta Neurochir (Wien); 1998; 140(12):1213-22. PubMed ID: 9932120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
    Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.